Pure Global AI
Myanmar flag

Myanmar medical device registration timeline

Source-linked clocks

Food and Drug Administration, Ministry of Health (FDA Myanmar) review clocks and end-to-end planning ranges, using the 4-class (A, B, C, D) — GHTF-aligned classification system.

1 pathways1 of 1 clocks verifiedvalidity Not published by DFDA. Five years is widely quoted by consultancies but appears in no DFDA instrument reachable here, so it is deliberately not carriedMDSAP not acceptedreviewed 2026-08-30fda.gov.mm
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Imported medical-device certificate(FDA Myanmar import review)
The DFDA Medical Device Section states an average 30-90 working-day review for imported devices. It is framed as an average rather than a service standard, and the Burmese text on the same slide drops the "working" qualifier the English carries
30-90 working days3-6 months—Verified
Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

Myanmar Medical Device Registration Process

Step-by-step FDA Myanmar registration process. Total estimated timeline: 3-6 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by FDA Myanmar. Appoint a Myanmar Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to FDA Myanmar including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

FDA Myanmar reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

30-90 working days

In-depth technical assessment of device safety and performance. FDA Myanmar may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, FDA Myanmar issues Myanmar market authorization certificate.

Summary: The Myanmar medical device registration process through Food and Drug Administration, Ministry of Health (FDA Myanmar) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
CE Mark (EU MDR)Usable as technical and QMS evidence in the import dossier. Myanmar has no Medical Device Act and DFDA publishes no recognition route, so a CE certificate carries no defined standing beyond the documents it supplies.None published
FDA 510(k)/PMAUsable as supporting technical evidence on the same terms as a CE certificate, with no recognition route behind it.None published
ASEAN member-state registrationDFDA published the ASEAN Medical Device Directive in October 2024 and applies its A-D classification, but the AMDD harmonises classification and dossier format rather than creating mutual recognition, and Myanmar has enacted no national decision period to shorten.None
Key requirements
  • Local Authorized Representative required for foreign manufacturers
  • The DFDA Medical Device Section runs four device services, and only the import one carries a published period. Local manufacture needs a manufacturing licence and then a product registration certificate for the domestic product; importation needs an Import Recommendation Certificate or an Import Notification Certificate. DFDA publishes the document checklists for the two local-manufacture services but no decision clock for either
  • 126 device types sit on the DFDA exemption list — 106 in the main list and 20 in the additional list — and need no Import Recommendation "for the time being", which is the fastest route to market for anything on it and is expressly revocable
  • Parallel imports are permitted but conditioned: an explanation letter and original letter of authorization from the product owner, a post-market commitment from the importer, and a separate DFDA notification certificate for every imported lot
  • Myanmar has not enacted a Medical Device Act. DFDA published the ASEAN Medical Device Directive in October 2024 and applies its A-D classification, but the AMDD leaves decision periods to national law and Myanmar has not set one
  • Political instability can extend practical timelines beyond published service standards
Primary regulator sources

Reviewed 2026-08-30. End-to-end totals remain planning estimates.

Keep researching this market
View the Myanmar resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against FDA Myanmar publications · full review 2026-08-30 · row IDs are stable — cite as registration-timeline:myanmar:import-certificate